Age-dependent effect of apolipoprotein E4 on functional outcome after controlled cortical impact in mice

Journal of Cerebral Blood Flow and Metabolism

Volumn 31, Issue 1, 2011, Pages 351-361

  Mannix, Rebekah C ^a   Zhang, Jimmy ^b   Park, Juyeon ^b   Zhang, Xuan ^b   Bilal, Kiran ^b   Walker, Kendall ^c   Tanzi, Rudolph E ^b   Tesco, Giuseppina ^c   Whalen, Michael J ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; developmental biology; genetics; traumatic brain injury

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; BRAIN WATER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLIOSIS; MALE; MAZE TEST; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPATIAL MEMORY; TRAUMATIC BRAIN INJURY;

AGING; AMYLOID BETA-PEPTIDES; ANIMALS; APOLIPOPROTEIN E4; BODY WATER; BRAIN; BRAIN CHEMISTRY; BRAIN INJURIES; COGNITION; HAND STRENGTH; IMMUNOHISTOCHEMISTRY; MAZE LEARNING; MEMORY; MICE; MICE, TRANSGENIC; MICROGLIA; PEPTIDE FRAGMENTS; POSTURAL BALANCE; PSYCHOMOTOR PERFORMANCE; RECOVERY OF FUNCTION; SPACE PERCEPTION;

EID: 78650875250     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2010.99     Document Type: Article

References (41)

1. Anderson V, Catroppa C, Morse S, Haritou F, Rosenfeld J (2005) Functional plasticity or vulnerability after early brain injury? Pediatrics 116:1374-82
2. Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, Piccardo P, Ghetti B, Paul SM (1997) Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet 17:263-4
3. Bermpohl D, You Z, Korsmeyer SJ, Moskowitz MA, Whalen MJ (2006) Traumatic brain injury in mice deficient in Bid: effects on histopathology and functional outcome. J Cereb Blood Flow Metab 26:625-33
4. Blackman JA, Worley G, Strittmatter WJ (2005) Apolipoprotein E and brain injury: implications for children. Dev Med Child Neurol 47:64-70
5. Brewer GJ (1998) Age-related toxicity to lactate, glutamate, and beta-amyloid in cultured adult neurons. Neurobiol Aging 19:561-8
6. Buttini M, Akeefe H, Lin C, Mahley RW, Pitas RE, Wyss-Coray T, Mucke L (2000) Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience 97:207-10
7. Buttini M, Yu GQ, Shockley K, Huang Y, Jones B, Masliah E, Mallory M, Yeo T, Longo FM, Mucke L (2002) Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation. J Neurosci 22:10539-48
8. Chen Y, Lomnitski L, Michaelson DM, Shohami E (1997) Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience 80:1255-62
9. Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, Holtzman DM, Zlokovic BV (2008) apoE isoformspecific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 118:4002-13
10. Ezra Y, Oron L, Moskovich L, Roses AD, Beni SM, Shohami E, Michaelson DM (2003) Apolipoprotein E4 decreases whereas apolipoprotein E3 increases the level of secreted amyloid precursor protein after closed head injury. Neuroscience 121:315-25
11. Hartman RE, Laurer H, Longhi L, Bales KR, Paul SM, McIntosh TK, Holtzman DM (2002) Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease. J Neurosci 22:10083-7
12. Hartman RE, Wozniak DF, Nardi A, Olney JW, Sartorius L, Holtzman DM (2001) Behavioral phenotyping of GFAPapoE3 and-apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology. Exp Neurol 170:326-44
13. Hiekkanen H, Kurki T, Brandstack N, Kairisto V, Tenovuo O (2007) MRI changes and ApoE genotype, a prospective 1-year follow-up of traumatic brain injury: a pilot study. Brain Inj 21:1307-14
14. Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, Mackey B, Olney J, McKeel D, Wozniak D, Paul SM (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 97:2892-7
15. James ML, Sullivan PM, Lascola CD, Vitek MP, Laskowitz DT (2009) Pharmacogenomic effects of apolipoprotein e on intracerebral hemorrhage. Stroke 40:632-9
16. Johnson VE, Stewart W, Smith DH (2010) Traumatic brain injury and amyloid-beta pathology: a link to Alzheimer's disease? Nat Rev Neurosci [e-pub ahead of print]
17. Jordan BD, Relkin NR, Ravdin LD, Jacobs AR, Bennett A, Gandy S (1997) Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. JAMA 278:136-40
18. Kerr ME, Ilyas Kamboh M, Yookyung K, Kraus MF, Puccio AM, DeKosky ST, Marion DW (2003) Relationship between apoE4 allele and excitatory amino acid levels after traumatic brain injury. Crit Care Med 31:2371-9
19. Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer's disease. Neuron 63:287-303
20. Loane DJ, Pocivavsek A, Moussa CE, Thompson R, Matsuoka Y, Faden AI, Rebeck GW, Burns MP (2009) Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nat Med 15:377-9
21. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155:853-62
22. Lynch JR, Tang W, Wang H, Vitek MP, Bennett ER, Sullivan PM, Warner DS, Laskowitz DT (2003) APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem 278:48529-33
23. Mandrekar S, Jiang Q, Lee CY, Koenigsknecht-Talboo J, Holtzman DM, Landreth GE (2009) Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J Neurosci 29:4252-62
24. Mayeux R, Ottman R, Maestre G, Ngai C, Tang MX, Ginsberg H, Chun M, Tycko B, Shelanski M (1995) Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology 45:555-7
25. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46:860-6
26. Moran LM, Taylor HG, Ganesaligam K, Gastier-Foster JM, Frick J, Bangert B, Dietrich A, Nuss KE, Rusin J, Wright M, Yeates KO (2009) Apolipoprotein E4 as a predictor of outcomes in pediatric mild traumatic brain injury. J Neurotrauma 26:1489-95
27. Nagano S, Huang X, Moir RD, Payton SM, Tanzi RE, Bush AI (2004) Peroxidase activity of cyclooxygenase-2 (COX-2) cross-links beta-amyloid (Abeta) and generates Abeta-COX-2 hetero-oligomers that are increased in Alzheimer's disease. J Biol Chem 279:14673-8
28. Nakagawa Y, Nakamura M, McIntosh TK, Rodriguez A, Berlin JA, Smith DH, Saatman KE, Raghupathi R, Clemens J, Saido TC, Schmidt ML, Lee VM, Trojanowski JQ (1999) Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging. J Comp Neurol 411:390-8
29. Nicoll JA (1996) Genetics and head injury. Neuropathol Appl Neurobiol 22:515-7
30. Raffai RL, Dong LM, Farese Jr RV, Weisgraber KH (2001) Introduction of human apolipoprotein E4 'domain interaction' into mouse apolipoprotein E. Proc Natl Acad Sci USA 98:11587-91
31. Sabo T, Lomnitski L, Nyska A, Beni S, Maronpot RR, Shohami E, Roses AD, Michaelson DM (2000) Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is neuroprotective whereas E4 increases fatalities. Neuroscience 101:879-84
32. Schneier AJ, Shields BJ, Hostetler SG, Xiang H, Smith GA (2006) Incidence of pediatric traumatic brain injury and associated hospital resource utilization in the United States. Pediatrics 118:483-92
33. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV (2000) Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptorrelated protein-1 at the blood-brain barrier. J Clin Invest 106:1489-99
34. Small DH (2009) Dysregulation of calcium homeostasis in Alzheimer's disease. Neurochem Res 34:1824-9
35. Sorbi S, Nacmias B, Piacentini S, Repice A, Latorraca S, Forleo P, Amaducci L (1995) ApoE as a prognostic factor for post-traumatic coma. Nat Med 1:852
36. Teasdale GM, Murray GD, Nicoll JA (2005) The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study. Brain 128:2556-61
37. Teasdale GM, Nicoll JA, Murray G, Fiddes M (1997) Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350:1069-71
38. Venkitaramani DV, Chin J, Netzer WJ, Gouras GK, Lesne S, Malinow R, Lombroso PJ (2007) Beta-amyloid modulation of synaptic transmission and plasticity. J Neurosci 27:11832-7
39. Vitek MP, Brown CM, Colton CA (2009) APOE genotypespecific differences in the innate immune response. Neurobiol Aging 30:1350-60
40. Wang DS, Dickson DW, Malter JS (2006) Beta-amyloid degradation and Alzheimer's disease. J Biomed Biotechnol 2006:58406
41. Wright RO, Hu H, Silverman EK, Tsaih SW, Schwartz J, Bellinger D, Palazuelos E, Weiss ST, Hernandez-Avila M (2003) Apolipoprotein E genotype predicts 24-month bayley scales infant development score. Pediatr Res 54:819-25